Ionut-Gabriel Funingana

7PUBLICATIONS
68CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 28, 2024
Coordinated protein modules define DNA damage responses to carboplatin at single cell resolution in human ovarian carcinoma models.

Jacob S Bedia, Ying-Wen Huang, Antonio Delgado Gonzalez

|Sep 26, 2023
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.

Philip Smith, Thomas Bradley, Lena Morrill Gavarró

|Jul 20, 2023
The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.

Philip Smith, Thomas Bradley, Lena Morrill Gavarró

|Jan 12, 2023
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors.

Ionut-Gabriel Funingana, Jacob S Bedia, Ying-Wen Huang

|Oct 26, 2022
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer.

Filipe Correia Martins, Dominique-Laurent Couturier, Ines de Santiago

Pageof 2